# Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

> **NCT02342223** · PHASE1 · COMPLETED · sponsor: **Jared Jagdeo, MD, MS** · enrollment: 20 (actual)

## Conditions studied

- HIV Facial Lipoatrophy

## Interventions

- **DEVICE:** Voluma

## Key facts

- **NCT ID:** NCT02342223
- **Lead sponsor:** Jared Jagdeo, MD, MS
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342223, "Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02342223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*